Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer’s disease
Sushant K. Shrivastava(Indian Institute of Technology BHU), Rakesh K. Srivastava(Northwell Health), Lalit Mohan Aggarwal(Institute of Medical Sciences), Avanish Tripathi(Indian Institute of Technology Indore), Priyanka Kumari Choubey(Banaras Hindu University), Subhash Chand Kheruka(Sanjay Gandhi Post Graduate Institute of Medical Sciences), Manish Tripathi(All India Institute of Medical Sciences), Manish Dixit(Texas A&M University), Piyoosh Sharma(Banaras Hindu University), Prabhash Nath Tripathi(Unknown), Saurabh K. Sinha(Mohanlal Sukhadia University), Digambar Kumar Waiker(Banaras Hindu University), Sharmila Shankar(Tulane University), Pavan Srivastava(Banaras Hindu University), Sanjay Gambhir(Sanjay Gandhi Post Graduate Institute of Medical Sciences)
Cited by 57
Related Papers
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
|Journal of Molecular Signaling|2010|374
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
|Progress in Neurobiology|2018|317
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer
|Frontiers in bioscience|2007|268